TransferMate set to become only cross-border payments company in EU with full U.S. regulatory approval, expands senior management
– Achieves full U.S. regulatory approval with acquisition of New York licence
– Post-Brexit, TransferMate will become only EU-based company with full U.S approval
– Announces expansion of senior management to accommodate rapid global expansion
– Appoints Gary Conroy, former MD Realex as Chief Commercial Officer
– Appoints Rafael de la Vega, former Director of Global Partnerships at Intuit in Silicon Valley, as North American Board advisor
– Appoints Pat McLoughlin, former CEO of Irish Payment Services Organization as Board Advisor for Europe
Ireland named best country for high-value FDI for sixth year in a row
Dublin, Ireland, July 27, 2017 – ICON plc (NASDAQ: ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the second quarter ended June 30, 2017.